If you are submitting for the first time, and you do not have an existing account, create a new account at “Journals.sbmu.ac.ir/basir”. Once you have logged in, you will be presented with the main menu and a link to your Author Center (Submit Manuscripts). Enter your Author Center to submit your manuscript. At the end of a successful submissionaconfirmationscreenwithmanuscriptnumberwillappearand you will receive an e-mail confirming that the manuscript has been received by the journal. If this does not happen, please check your submission and /or contact our help desk at firstname.lastname@example.org.
The manuscript should be prepared according to the journal style, using American English spelling and punctuation. Authors must submit their manuscript electronically to expedite the peer review process online at :http://journals.sbmu.ac.ir/basir/about/submissions#onlineSubmissions; alternatively you can submit your article using Email by sending the complete manuscript including the cover letter, title page, the manuscript body, table and figures to: email@example.com.
The Peer Review System: Manuscripts will be reviewed primarily by the editorial board. They will be considered if they are in line with the standards of the journal. If the editors find major faults in their structure, they will be rejected. Papers which pass the primary evaluation are then peer-reviewed by two or three external reviewers.
By submitting your manuscript to the journal you confirm that it is an unpublished work and not under consideration elsewhere. Authors should follow the standards with respect to publication ethics as described by the Commission on Publication Ethics (COPE). Plagiarism, falsification or fabrication of data including duplicate publication of the authors’ own work without proper citation are unacceptable practices. Any cases of ethical misconduct are treated very seriously and will be dealt with in accordance with the COPE guidelines.
As part of the submission process, corresponding authors are required to confirm whether they or their co-authors have any conflicts of interest to declare, and to provide details of these conflicts if present. If the manuscript is published, conflict of interest information will be communicated in a statement in the published paper.
Clinical trials should be conducted in accordance with the ethical principles that have their origin in the Declaration of Helsinki. Also all clinical trials submitted to this journal should have been registered in a public trials registry at or before the time of first patient enrollment as a condition of consideration for publication.
Original Articles: shouldcontaintitlepage, abstract, keywords, introduction, materials and methods, results, discussion, and references sections. The length of the text should be limited to 3000 words excluding the references and abstract. Clinical trials should contain patients’ informed consent and the approval of the ethics committee of the corresponding institution. The number of references should be limited to 50 references for original articles.
Case Reports: should not exceed 1500 words and should include abstract, keywords, introduction, case presentation, discussion, conclusion, references, and 1 to 4 figures or tables. Necessarydocumentations of the case(s) like ophthalmic pathology and laboratory test reports should be included. The number of references should be limited to 20 references for case reports.
Review Articles: might be requested by the editor, but JOOS will also accept submitted reviews. Both solicited and unsolicited review articles are subjected to editorial and peer review similar to original articles. The number of references should be limited to 85 references for review articles.
Letters to editor: Joos accepts letters to editor. Letter should be less than 500 words. Letters might discuss article published in the journal during the previous 6 months.
Structure of Article
Title Page: the first page of the manuscript should contain the following information: (1) Title of the paper; (2) Authors’ names; (3) Authors’ affiliations; (4) Authors’ ORCID ID; (5) Acknowledgements for research support; (6) Name, address, email, phone number and fax number of corresponding author; (7) Any financial interests, direct or indirect, that exist or may be perceived to exist for individual contributors in connection with the manuscript and a short title.
Abstract: abstract for original papers should contain purpose, materials and methods, results, and conclusion sections separately. The objective of the study, findings (including its statistical significance), and the conclusion made on the basis of the findings should be clearly presented. Forcasereportsa one paragraph, non-structured abstract or astructuredabstractdividedtobackground, report of the case and conclusion are both acceptable.
Please do not include any references in your Abstract. Make sure it serves both as a general introduction to the topic and as a brief, non-technical summary of the main results and their implications.
Nevertheless, the length of an abstract should be less than 250 words (150 words for case reports).
Keywords: each submitted article should contain three or more keywords, which must be chosen considering the Medical Subject Headings (MeSH) suggestions.
Body of the manuscript: the article body should be organized and formatted according to the following headings:
Authors may use “Patients and Methods” instead of “Materials and Methods” in papers dealing with human subjects. The body of the paper must be written as concisely as possible. The body of case reports should not exceed 1500 words and should include introduction, case report, discussion and conclusion sections as well as references, and 1 to 4 figures or tables.
Use the same typeface in the same font size for all figures in your paper.
Put all display items on a white background, and avoid excessive boxing, unnecessary colour, spurious decorative effects (such as three-dimensional 'skyscraper' histograms) and highly pixelated computer drawings.
Never truncate the vertical axis of histograms to exaggerate small differences.
Ensure any labelling is of sufficient size and contrast to be legible, even after appropriate reduction.
Lettering in figures should be in lower-case type, with only the first letter of each label capitalised.
Display items are limited to 8 (figures and/or tables). However, to enable typesetting of papers, we advise making the number of display items commensurate with your overall word length. So, for Articles of 2,000 words or less, we suggest including no more than 4 figures/tables.
Please note, footnotes should not be used.
Preparing tables and figures: Tables and figures must be listed in the order cited in the text using Arabic numerals. Tables should be presented each on a separate page. Tables and figures should not be embedded in the text, but should be uploaded as separate files. A short descriptive title should appear above each table with a clear legend and any footnotes or captions suitably identified below. Provide headings for all columns and indicate units of measurement, where applicable.
Illustrations: For highest quality reproduction of illustrations we recommendsubmittingeachfigureashigh resolution TIFF (300 dpi minimum) or EPS (800 dpi) files with any fonts embedded. Colour illustrations will be considered for publication.
Prepare double-blind review files
This journal uses a double-blind review, which means that both the reviewer and author identities are concealed from the reviewers, and vice versa, throughout the review process.
To facilitate this, authors also need to upload a blind manuscript. They have to ensure that their manuscripts are prepared in a way that does not give their identity. To help with this preparation please prepare and submit a blind manuscript as follows:
If your paper contains statistical testing, it should state the name of the statistical test, the n value for each statistical analysis, the comparisons of interest, a justification for the use of that test (including, for example, a discussion of the normality of the data when the test is appropriate only for normal data), the alpha level for all tests, whether the tests were one-tailed or two-tailed, and the actual P-value for each test (not merely "significant" or "P < 0.05"). Please make it clear what statistical test was used to generate every P-value. Use of the word "significant" should always be accompanied by a P-value; otherwise, use "substantial," "considerable," etc.
Data sets should be summarised with descriptive statistics, which should include the n value for each data set, a clearly labelled measure of centre (such as the mean or the median), and a clearly labelled measure of variability (such as standard deviation or range).
Ranges are more appropriate than standard deviations or standard errors for small data sets. Graphs should include clearly labelled error bars. You must state whether a number that follows the ± sign is a standard error (s.e.m.) or a standard deviation (s.d.).
You must justify the use of a particular test and explain whether the data conforms to the assumptions of the tests. Three errors are particularly common:
The presentation of specific details about instruments used, sources of specialized chemicals, and related experimental details should be incorporated into the text of the Experimental Section as a paragraph headed General Experimental Procedures.
You should identify molecular structures by bold, Arabic numerals assigned in order of presentation in the text. Once identified in the main text or a figure, you may refer to compounds by their name, by a defined abbreviation, or by the bold Arabic numeral (as long as the compound is referred to consistently as one of these three).
When possible, you should refer to chemical compounds and biomolecules using systematic nomenclature, preferably using IUPAC. You should use standard chemical and biological abbreviations. Make sure you define unconventional or specialist abbreviations at their first occurrence in the text.
You should use approved nomenclature for gene symbols, and employ symbols rather than italicised full names (for example Ttn, not titin). Please consult the appropriate nomenclature databases for correct gene names and symbols. A useful resource is Entrez Gene.
You can get approved human gene symbols from HUGO Gene Nomenclature Committee (HGNC), e-mail: firstname.lastname@example.org; see also www.genenames.org.
You can get approved mouse symbols from The Jackson Laboratory, e-mail: email@example.com.
For proposed gene names that are not already approved, please submit the gene symbols to the appropriate nomenclature committees as soon as possible, as these must be deposited and approved before the publication of an article.
The authors are responsible for the accuracy of references, which must be numbered respectively in the order of citation in the text. Reference citations should be marked by Arabic numbers. Personal communications and unpublished data including manuscripts submitted but not yet accepted for publication should not be used as a reference; however, they may be placed in parentheses in the text.
Journal titles should be abbreviated according to Index Medicus. Inclusive page numbers should be given for all references. Do not forget to include the volume and issue numbers for all references when available. Shortenthesecondpagenumberwhen appropriate.
Presented below, are references to a journal, a chapter in a book, and a book, respectively, in the style requested by our journal:
LLago Ade M, Nassaralla BR, Stival LR, Nassaralla Junior JJ. Changes in corneal sensitivity following cross-linking for progressive early-stage keratoconus. Arq Bras Oftalmol. 2014;77(2):84-7.
To use this citation style, please set the Endnote style in the Microsoft Word plugin to "NLM".
Book: Ringscen MK, Bond D. Gerontology and leadership skills for nurses, 2nd ed. Albany, NY: Delmar Publishers,1996.
Chapter in Book: Phillips SJ, Whisnant JP. Hypertension and Stroke. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis, and management, 2nd ed. New York: Raven Press, 1995, 465-78.
When there are six or less authors, surnames and initials of all authors should be mentioned. In the case of seven or more authors, the names of the first six authors followed by et al. should be given.
Shortt AJ, Bunce C, Levis HJ, Blows P, Doré CJ,VernonA, et al. Three-year outcomes of cultured limbal epithelial allografts in aniridia and Stevens-Johnson syndrome evaluated using the Clinical Outcome Assessment in Surgical Trials assessment tool. Stem Cells Transl Med. 2014;3(2):265-75.
All manuscripts submitted to Journal of Ophthalmic and Optometric Sciences must be submitted solely to this journal, should not have been published in any part or form in another publication of any type, professional or lay, and will become the property of the publisher. Any material reproduced or adapted from any other published or unpublished sources must be duly acknowledged. It is the authors’ responsibility to obtain permission to reproduce copyrighted material.
Upon acceptance of a manuscript for publication, the author will be requested to sign an agreement transferring copyright to the publisher, who reserves the copyright. Material published in this journal may not be reproduced or published elsewhere without the written permission of the publisher and the author. All statements in, or omissions from, published manuscripts are the responsibility of the author who will assist the editor and publisher by reviewing proofs.
No page charges will be levied against authors or their institutions for publication in this journal. All authors should have contributed in a significant manner and be in agreement with all content in the manuscript. The corresponding author will takeresponsibilityforthisrequirementbeing met.
Offprint: all authors will receive one off print free of charge.
Permission: it is the responsibility of the author to obtain written permission for a quotation from unpublished materials, or for all quotations in excess of 250 words in one extract, or, 500 words in total from any work still in copyright, and for the reprinting of figures or tables from unpublished or copyrighted material.
If your research includes human or animal subjects, you will need to include the appropriate ethics declarations in the Methods section of your manuscript.
Please note that:
You should submit any Supplementary Information together with the manuscript so that we can send it to referees during peer-review. This will be published online with accepted manuscripts.
Journal of Ophthalmic and Optometric Sciences (JOOS) encourages all authors and reviewers to register for an ORCiD. ORCiD provides a persistent digital identifier that distinguishes you from every other researcher. Besides ensuring your research always remains identified with you for citations and usage statistics, an authenticated ORCiD account allows you to sign on to Editorial Manager with a single step and enables you to toggle between all journals in which you have registrations, as an author, reviewer and/or editor.
For more information on ORCiD, please visit their website: http://orcid.org/
Copyright and Creative Commons license
The corresponding author is responsible for completing and returning the signed Open Access Agreement to the editorial office or the publisher. Open Access Agreement willbesenttocorresponding author once the article is accepted. Our Journal publishes open access articles under a Creative Commons license. With Creative Commons licenses, the author retains copyright and the public is allowed to reuse the content. The authors grant JOOS a license to publish the article and to identify as the original publisher.
Editorial Office: 4th floor, Basir Eye Health Research Center, # 3, Sheibani Alley, North Jamalzadeh Street, Tehran, Iran.
Postal Code: 1418643561
Copyright and Creative Commons license
The corresponding author is responsible for completing and returning the signed Open Access Agreement to the editorial office or the publisher. Open Access Agreement will be sent to corresponding author once the article is accepted. Our Journal publishes open access articles under a Creative Commons license. With Creative Commons licenses, the author retains copyright and the public is allowed to reuse the content. The authors grant JOOS a license to publish the article and to identify as the original publisher.